NCT01503515
Clinical Trial Information
Trial Number: NCT01503515 (ClinicalTrials.gov)
Disease Type:
- Immune Disorder (excluding AIDS and malignancy) - Miscellaneous
- Miscellaneous Neoplasm - Other
Trial Title:
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Study ID:
ACCL1131
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®